102 related articles for article (PubMed ID: 20889595)
1. Increased risk of autoimmune disease in families with Wegener's granulomatosis.
Knight A; Sandin S; Askling J
J Rheumatol; 2010 Dec; 37(12):2553-8. PubMed ID: 20889595
[TBL] [Abstract][Full Text] [Related]
2. Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease.
Knight A; Sandin S; Askling J
Arthritis Rheum; 2008 Jan; 58(1):302-7. PubMed ID: 18163522
[TBL] [Abstract][Full Text] [Related]
3. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions.
Hemminki K; Li X; Sundquist J; Sundquist K
Arthritis Rheum; 2009 Mar; 60(3):661-8. PubMed ID: 19248111
[TBL] [Abstract][Full Text] [Related]
4. The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event.
Sebastian JK; Voetsch B; Stone JH; Romay-Penabad Z; Lo GH; Allen NB; Davis JC; Hoffman GS; McCune WJ; St Clair EW; Specks U; Spiera R; Loscalzo J; Pierangeli S; Merkel PA;
J Rheumatol; 2007 Dec; 34(12):2446-50. PubMed ID: 17918782
[TBL] [Abstract][Full Text] [Related]
5. Thrombosis and pediatric Wegener's granulomatosis: acquired and genetic risk factors for hypercoagulability.
von Scheven E; Lu TT; Emery HM; Elder ME; Wara DW
Arthritis Rheum; 2003 Dec; 49(6):862-5. PubMed ID: 14673976
[No Abstract] [Full Text] [Related]
6. Fcgamma receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse.
Dijstelbloem HM; Scheepers RH; Oost WW; Stegeman CA; van der Pol WL; Sluiter WJ; Kallenberg CG; van de Winkel JG; Tervaert JW
Arthritis Rheum; 1999 Sep; 42(9):1823-7. PubMed ID: 10513795
[TBL] [Abstract][Full Text] [Related]
7. NOD2/CARD15 gene mutation is not associated with susceptibility to Wegener's granulomatosis.
Newman B; Rubin LA; Siminovitch KA
J Rheumatol; 2003 Feb; 30(2):305-7. PubMed ID: 12563685
[TBL] [Abstract][Full Text] [Related]
8. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis.
Jagiello P; Aries P; Arning L; Wagenleiter SE; Csernok E; Hellmich B; Gross WL; Epplen JT
Arthritis Rheum; 2005 Dec; 52(12):4039-43. PubMed ID: 16320352
[TBL] [Abstract][Full Text] [Related]
9. Analysis of a biomarker for Wegener's granulomatosis.
Cooley P; Taylor KH; Czika W; Seifer C; Taylor JF
Int J Immunogenet; 2005 Aug; 32(4):237-43. PubMed ID: 16026591
[TBL] [Abstract][Full Text] [Related]
10. Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis.
Zhou Y; Huang D; Farver C; Hoffman GS
J Rheumatol; 2003 Jul; 30(7):1541-7. PubMed ID: 12858455
[TBL] [Abstract][Full Text] [Related]
11. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
Knight A; Askling J; Granath F; Sparen P; Ekbom A
Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
[TBL] [Abstract][Full Text] [Related]
12. Inner ear deafness in Wegener's granulomatosis.
Luqmani R; Jubb R; Emery P; Reid A; Adu D
J Rheumatol; 1991 May; 18(5):766-8. PubMed ID: 1865429
[TBL] [Abstract][Full Text] [Related]
13. On the genetic contribution to selected multifactorial diseases with autoimmune characteristics.
Miterski B; Epplen JT; Gencik M
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):331-41. PubMed ID: 12030439
[TBL] [Abstract][Full Text] [Related]
14. Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis.
Faurschou M; Mellemkjaer L; Sorensen IJ; Svalgaard Thomsen B; Dreyer L; Baslund B
Arthritis Rheum; 2009 Apr; 60(4):1187-92. PubMed ID: 19333952
[TBL] [Abstract][Full Text] [Related]
15. An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener's granulomatosis.
Zhou Y; Huang D; Paris PL; Sauter CS; Prock KA; Hoffman GS
Arthritis Rheum; 2004 Aug; 50(8):2645-50. PubMed ID: 15334480
[TBL] [Abstract][Full Text] [Related]
16. Rapidly progressive glomerulonephritis and Wegener's granulomatosis.
Andrassy K
Nephrologie; 1992; 13(6):279-81. PubMed ID: 1299788
[TBL] [Abstract][Full Text] [Related]
17. Occupational risk factors for Wegener's granulomatosis: a case-control study.
Knight A; Sandin S; Askling J
Ann Rheum Dis; 2010 Apr; 69(4):737-40. PubMed ID: 19364729
[TBL] [Abstract][Full Text] [Related]
18. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
Seo P; Min YI; Holbrook JT; Hoffman GS; Merkel PA; Spiera R; Davis JC; Ytterberg SR; St Clair EW; McCune WJ; Specks U; Allen NB; Luqmani RA; Stone JH;
Arthritis Rheum; 2005 Jul; 52(7):2168-78. PubMed ID: 15986348
[TBL] [Abstract][Full Text] [Related]
19. Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis.
Spriewald BM; Witzke O; Wassmuth R; Wenzel RR; Arnold ML; Philipp T; Kalden JR
Ann Rheum Dis; 2005 Mar; 64(3):457-61. PubMed ID: 15708894
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of Wegener's granulomatosis: current concepts.
Sarraf P; Sneller MC
Expert Rev Mol Med; 2005 May; 7(8):1-19. PubMed ID: 15890083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
